Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
International Journal of Molecular Sciences|August 7, 2021
The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and ChallengesYoussef Bouferraa, Andrea Chedid, Ghid Amhaz, et al.Frontiers in Oncology|May 23, 2022
From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis CascadeAli H Abdel Sater, Youssef Bouferraa, Ghid Amhaz, et al.International Journal of Molecular Sciences|January 21, 2022
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021Gracia Fahed, Laurence Aoun, Morgan Bou Zerdan, et al.Cancers|October 14, 2022
Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal AdenocarcinomaMaroun Bou Zerdan, Malek Shatila, Dhruv Sarwal, et al.Journal of Cosmetic Dermatology|April 5, 2021
Pathophysiology, clinical findings, and management of Fox-Fordyce disease: A systematic reviewAntoine Salloum, Youssef Bouferraa, Nagham Bazzi, et al.BMC Cancer|December 12, 2022
A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO)Charbel Elias, Youssef H Zeidan, Youssef Bouferraa, et al.Molecular and Clinical Oncology|September 3, 2021
Total neoadjuvant therapy in patients with locally advanced rectal cancer: A tertiary medical center experienceZiad El Husseini, Yolla Haibe, Youssef Bouferraa, et al.Current Alzheimer Research|December 29, 2022
The Gut Microbiome and Alzheimer's Disease: A Growing RelationshipMaroun Bou Zerdan, Elsa Hebbo, Ali Hijazi, et al.BMC Cancer|January 4, 2022
The impact of young age (< 40 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective studyYoussef Bouferraa, Yolla Haibe, Andrea Chedid, et al.Oncotarget|May 15, 2023
Systemic AL amyloidosis: current approach and future directionMaroun Bou Zerdan, Lewis Nasr, Farhan Khalid, et al.Pageof 3